LabGenomics to Promote Supply of 'COVID-19' Diagnostic Kits to the US
[Asia Economy Reporter Hyunseok Yoo] LabGenomics, a healthcare company specializing in molecular diagnostic testing, announced on the 11th that it is promoting the supply of its novel coronavirus (COVID-19) diagnostic kits to the United States. The company has signed basic supply contracts with partner companies of the state governments of Nevada, Washington, and New Jersey.
These partners participate in the procurement operations of each state government and supply diagnostic equipment and medical consumables to medical institutions within the state governments. Through these partners, the company plans to provide test diagnostic kits to each state government, and after performance evaluation, supply them to the U.S. market through the partners.
Hot Picks Today
600 Million vs. 460 Million vs. 160 Million... Samsung Electronics DS Division: "Three Paychecks Under One Roof"
- Opening a Bank Account in Korea Is Too Difficult..."Over 150,000 Won in Notarization Fees Just for a Child's Account and Debit Card" [Foreigner K-Finance Status]②
- "Disappointing Results: 80% of Sunscreens Found Lacking in Safety and Effectiveness"
- Refusing Access to Apartment Management Fee Ledgers to Be Punished by Prison or Fines... Penalties to Be Increased
- "Who Is Visiting Japan These Days?" The Once-Crowded Tourist Spots Empty Out... What's Happening?
With this contract, LabGenomics will supply COVID-19 diagnostic kits to the U.S. market following the Middle East and Europe regions. In response to the global spread of COVID-19, the company plans to further strengthen its overseas sales network.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
!["Please Help Us": How Much Do Those Bowing Deeply for Your Vote Really Earn? [Data Pick]](https://cwcontent.asiae.co.kr/asiaresize/307/2026052010120870131_1779239528.png)
